Literature DB >> 24379438

Nrf2 enhances cholangiocyte expansion in Pten-deficient livers.

Keiko Taguchi1, Ikuo Hirano, Tohru Itoh, Minoru Tanaka, Atsushi Miyajima, Akira Suzuki, Hozumi Motohashi, Masayuki Yamamoto.   

Abstract

Keap1-Nrf2 system plays a central role in the stress response. While Keap1 ubiquitinates Nrf2 for degradation under unstressed conditions, this Keap1 activity is abrogated in response to oxidative or electrophilic stresses, leading to Nrf2 stabilization and coordinated activation of cytoprotective genes. We recently found that nuclear accumulation of Nrf2 is significantly increased by simultaneous deletion of Pten and Keap1, resulting in the stronger activation of Nrf2 target genes. To clarify the impact of the cross talk between the Keap1-Nrf2 and Pten-phosphatidylinositide 3-kinase-Akt pathways on the liver pathophysiology, in this study we have conducted closer analysis of liver-specific Pten::Keap1 double-mutant mice (Pten::Keap1-Alb mice). The Pten::Keap1-Alb mice were lethal by 1 month after birth and displayed severe hepatomegaly with abnormal expansion of ductal structures comprising cholangiocytes in a Nrf2-dependent manner. Long-term observation of Pten::Keap1-Alb::Nrf2(+/-) mice revealed that the Nrf2-heterozygous mice survived beyond 1 month but developed polycystic liver fibrosis by 6 months. Gsk3 directing the Keap1-independent degradation of Nrf2 was heavily phosphorylated and consequently inactivated by the double deletion of Pten and Keap1 genes. Thus, liver-specific disruption of Keap1 and Pten augments Nrf2 activity through inactivation of Keap1-dependent and -independent degradation of Nrf2 and establishes the Nrf2-dependent molecular network promoting the hepatomegaly and cholangiocyte expansion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24379438      PMCID: PMC4023823          DOI: 10.1128/MCB.01384-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

1.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

2.  Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver.

Authors:  Ichiro Onoyama; Atsushi Suzuki; Akinobu Matsumoto; Kengo Tomita; Hideki Katagiri; Yuichi Oike; Keiko Nakayama; Keiichi I Nakayama
Journal:  J Clin Invest       Date:  2010-12-01       Impact factor: 14.808

3.  Selective induction of the tumor marker glutathione S-transferase P1 by proteasome inhibitors.

Authors:  Hiroko Usami; Yuri Kusano; Takeshi Kumagai; Shigehiro Osada; Ken Itoh; Akira Kobayashi; Masayuki Yamamoto; Koji Uchida
Journal:  J Biol Chem       Date:  2005-04-29       Impact factor: 5.157

4.  Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice.

Authors:  Xiaoling Xu; Shogo Kobayashi; Wenhui Qiao; Cuiling Li; Cuiying Xiao; Svetlana Radaeva; Bangyan Stiles; Rui-Hong Wang; Nobuya Ohara; Tadashi Yoshino; Derek LeRoith; Michael S Torbenson; Gregory J Gores; Hong Wu; Bin Gao; Chu-Xia Deng
Journal:  J Clin Invest       Date:  2006-06-08       Impact factor: 14.808

5.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements.

Authors:  K Itoh; T Chiba; S Takahashi; T Ishii; K Igarashi; Y Katoh; T Oyake; N Hayashi; K Satoh; I Hatayama; M Yamamoto; Y Nabeshima
Journal:  Biochem Biophys Res Commun       Date:  1997-07-18       Impact factor: 3.575

6.  Genetic analysis of cytoprotective functions supported by graded expression of Keap1.

Authors:  Keiko Taguchi; Jonathan M Maher; Takafumi Suzuki; Yukie Kawatani; Hozumi Motohashi; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2010-04-19       Impact factor: 4.272

7.  Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis.

Authors:  Hironori Satoh; Takashi Moriguchi; Jun Takai; Masahito Ebina; Masayuki Yamamoto
Journal:  Cancer Res       Date:  2013-04-22       Impact factor: 12.701

8.  Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.

Authors:  Yasuo Horie; Akira Suzuki; Ei Kataoka; Takehiko Sasaki; Koichi Hamada; Junko Sasaki; Katsunori Mizuno; Go Hasegawa; Hiroyuki Kishimoto; Masahiro Iizuka; Makoto Naito; Katsuhiko Enomoto; Sumio Watanabe; Tak Wah Mak; Toru Nakano
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

9.  Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis.

Authors:  Anju Singh; Christine Happel; Soumen K Manna; George Acquaah-Mensah; Julian Carrerero; Sarvesh Kumar; Poonam Nasipuri; Kristopher W Krausz; Nobunao Wakabayashi; Ruby Dewi; Laszlo G Boros; Frank J Gonzalez; Edward Gabrielson; Kwok K Wong; Geoffrey Girnun; Shyam Biswal
Journal:  J Clin Invest       Date:  2013-06-10       Impact factor: 14.808

10.  Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet.

Authors:  Chunhua Wang; Yizhe Cui; Chunyan Li; Yanhua Zhang; Shang Xu; Xiaochong Li; Hong Li; Xiuying Zhang
Journal:  Lipids Health Dis       Date:  2013-11-04       Impact factor: 3.876

View more
  35 in total

Review 1.  Functional role of cellular senescence in biliary injury.

Authors:  Luke Meng; Morgan Quezada; Phillip Levine; Yuyan Han; Kelly McDaniel; Tianhao Zhou; Emily Lin; Shannon Glaser; Fanyin Meng; Heather Francis; Gianfranco Alpini
Journal:  Am J Pathol       Date:  2015-01-22       Impact factor: 4.307

2.  Tocotrienols Influence Body Weight Gain and Brain Protein Expression in Long-Term High-Fat Diet-Treated Mice.

Authors:  Yugo Kato; Yoshinori Aoki; Koji Fukui
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

3.  Glucocorticoid receptor signaling represses the antioxidant response by inhibiting histone acetylation mediated by the transcriptional activator NRF2.

Authors:  Md Morshedul Alam; Keito Okazaki; Linh Thi Thao Nguyen; Nao Ota; Hiroshi Kitamura; Shohei Murakami; Hiroki Shima; Kazuhiko Igarashi; Hiroki Sekine; Hozumi Motohashi
Journal:  J Biol Chem       Date:  2017-03-17       Impact factor: 5.157

Review 4.  The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway.

Authors:  Liam Baird; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2020-06-15       Impact factor: 4.272

Review 5.  CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis.

Authors:  Liqing Yu; Yi Li; Alison Grisé; Huan Wang
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

6.  Profiling changes in metabolism and the immune microenvironment in lung tumorigenesis.

Authors:  Di Zhang; Ana S Leal; Fawzi Abu Rous; Karen T Liby
Journal:  Ann Transl Med       Date:  2019-07

7.  WNT-3A regulates an Axin1/NRF2 complex that regulates antioxidant metabolism in hepatocytes.

Authors:  Patricia Rada; Ana I Rojo; Anika Offergeld; Gui Jie Feng; Juan P Velasco-Martín; José Manuel González-Sancho; Ángela M Valverde; Trevor Dale; Javier Regadera; Antonio Cuadrado
Journal:  Antioxid Redox Signal       Date:  2014-12-09       Impact factor: 8.401

Review 8.  Nitric oxide in liver diseases.

Authors:  Yasuko Iwakiri; Moon Young Kim
Journal:  Trends Pharmacol Sci       Date:  2015-05-28       Impact factor: 14.819

9.  The Mediator Subunit MED16 Transduces NRF2-Activating Signals into Antioxidant Gene Expression.

Authors:  Hiroki Sekine; Keito Okazaki; Nao Ota; Hiroki Shima; Yasutake Katoh; Norio Suzuki; Kazuhiko Igarashi; Mitsuhiro Ito; Hozumi Motohashi; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2015-11-16       Impact factor: 4.272

10.  Nuclear Factor Erythroid 2-Related Factor 2 Deficiency Results in Amplification of the Liver Fat-Lowering Effect of Estrogen.

Authors:  Wenjuan Rui; Yuhong Zou; Joonyong Lee; Shashank Manohar Nambiar; Jingmei Lin; Linjie Zhang; Yan Yang; Guoli Dai
Journal:  J Pharmacol Exp Ther       Date:  2016-05-09       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.